Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12109202 | Fixed dose combination of cholinesterase inhibitor and a quaternary ammonium antimuscarinic agent to treat neurodegenerative cognitive disorders | — | 2024-10-08 |
| 11419850 | Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases | — | 2022-08-23 |
| 10519109 | Glycopyrronium fatty acid salts and methods of making same | Emerich Eisenreich, Xuejun Liu, Bingidimi I. Mobele, Satish Puppali | 2019-12-31 |
| 10487464 | Traffic cone | — | 2019-11-26 |
| 10376493 | Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases | — | 2019-08-13 |
| D854957 | Traffic cone | — | 2019-07-30 |
| 10323370 | Traffic cone | — | 2019-06-18 |
| 9980941 | Quaternary ammonium anti-cholinergic muscarinic receptor antagonists | — | 2018-05-29 |
| D791002 | Traffic cone | — | 2017-07-04 |
| D791001 | Traffic cone | — | 2017-07-04 |
| D778194 | Traffic cone | — | 2017-02-07 |
| 9084753 | Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium | — | 2015-07-21 |
| 9034890 | Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases | — | 2015-05-19 |
| 8969402 | Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases | — | 2015-03-03 |
| 8097633 | Uses for quaternary ammonium anticholinergic muscarinic receptor antagonists in patients being treated for cognitive impairment or acute delirium | — | 2012-01-17 |
| 6060279 | Interferon-.alpha.-induced protein | Paul S. Masters | 2000-05-09 |
| 5834235 | Inferferon-.alpha.-induced protein | Paul S. Masters | 1998-11-10 |